S
"S" is a word and design mark owned by Hangzhou SoliPharma Co., Ltd., filed at the USPTO on July 31, 2020. It was abandoned and covers classes 5, 35, 42 and 44.
- Status
- Abandoned
- Since April 17, 2023
- Filed
- July 31, 2020
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 90086260
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 4 classes
Who owns S
The owner and representative on file with the office.
Owner
Hangzhou SoliPharma Co., Ltd.
Hangzhou, Zhejiang,, China
Representative
Monica Riva Talley
Sterne Kessler Goldstein & Fox PLLC
What the mark covers
The products and services S is filed for, grouped by Nice class.
Antibiotics; Collyrium; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, cognitive disorders, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Pharmaceutical preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Biological preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Prescription and non-prescription medicines, namely, injectable pharmaceuticals, pills, tablets, capsules, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion, suppository and pharmaceutical preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Drug delivery agents in the form of powders, tablets, capsules, injectable pharmaceuticals, pills, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Diagnostic preparations for veterinary purposes; Veterinary preparations, namely, pain relief medication, anti-infective medication, immune disease medication, respiratory disease medication, allergy and pain related medication, digestive system medication, urinary system medication, cardiovascular and cerebrovascular medication, tumor medication, blood disease medication, hyperproliferative disease medication, blood vessel disease medication, skin disease medication, obesity medication, chronic pain medication and endocrine disease medication
Demonstration of goods; Advertising services; online advertising on a computer network; Business management and organization consultancy; Business management consultancy; Business investigations; Professional business consultancy; Import-export agency services; Publication of publicity texts; Commercial information agency services; Market analysis; providing commercial information and advice for consumers in the choice of products and services; Provision of an online marketplace for buyers and sellers of goods and services; Organizing exhibitions for technology for business purposes; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
Research and development of new products for others; Scientific research; Chemical analysis; Chemical research; Biological research; Cosmetic research; Medical research; Development of pharmaceutical preparations and medicines; Conducting clinical trials for others, being scientific research; Inspection of medical equipment for quality control purposes; Chemical engineering; Technology consultation in the field of medical research; Research and development of technology in the field of medical research
Pharmaceutical advice; Health counselling; Beauty salon services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Alternative medicine services; Food nutrition consultancy; Health care; Nursing, medical; Medical and pharmaceutical consultation; Telemedicine services; Pharmacists' services to make up prescriptions; Nutritional therapy services; Veterinary services, namely, veterinary assistance; Hygienic and beauty care; Charitable services, namely, providing medical services to underdeveloped countries; Charitable services, namely, providing medical equipment and services to underserved communities
What has happened so far
Steps recorded by the USPTO, newest first.
- Abandonment notice e-mailed - inter partes decision
- Abandonment - after inter partes decision
- Opposition terminated no. 999999
- Opposition dismissed no. 999999
- Opposition instituted no. 999999
- Extension of time to oppose received
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About S
Who owns the trademark "S"?
The USPTO trademark "S" (application 90086260) is owned by Hangzhou SoliPharma Co., Ltd.
What is the status of "S"?
Its status at the USPTO is: abandoned.
Get this data via the API
Everything on this page comes from the Signa API. Pull S and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2c05-b923-7149-b997-64d363fecfec
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2c05-b923-7149-b997-64d363fecfec",
"object": "trademark",
"mark_text": "S",
"status": {
"primary": "inactive",
"stage": "abandoned"
},
"office_code": "US",
"application_number": "90086260",
"filing_date": "2020-07-31",
"nice_classes": [
5,
35,
42,
44
],
"owners": [
{
"name": "Hangzhou SoliPharma Co., Ltd.",
"entity_id": null
}
]
}